Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Indirect Calorimetry-Guided Nutritional Support in Mechanically Ventilated Children (CALI-PED) (CALI-PED)

tiistai 10. marraskuuta 2026 päivittänyt: University Hospital, Montpellier

Use of Indirect Calorimetry to Guide Caloric Intake in Children on Mechanical Ventilation in the Pediatric Intensive Care Unit: A Prospective Comparative Study

Adequate nutritional support is essential in critically ill children receiving invasive mechanical ventilation. Current nutritional prescriptions are commonly based on predictive equations, which may inaccurately estimate individual energy requirements and contribute to underfeeding or overfeeding.

CALI-PED is a single-center, prospective, interventional pilot study designed to evaluate whether indirect calorimetry-guided nutritional support reduces interindividual variability in energy intake adequacy among mechanically ventilated children in the pediatric intensive care unit (PICU).

Fifty children will be prospectively enrolled and compared with a historical cohort of 141 patients managed using conventional nutritional targets based on the Schofield predictive equation. In the prospective cohort, resting energy expenditure will be measured daily using indirect calorimetry, for up to seven days of invasive mechanical ventilation, and enteral caloric prescriptions will be adjusted accordingly.

The primary outcome is the interindividual variability in the ratio of actual energy intake to the reference energy target on days 2 and 3 of mechanical ventilation. Secondary outcomes include protein intake, agreement between predicted and measured energy requirements, changes in resting energy expenditure over time, duration of mechanical ventilation, PICU length of stay, and incidence of nosocomial infections.

This pilot study aims to determine whether indirect calorimetry can improve the individualization and consistency of nutritional support in critically ill children.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

**Background and Rationale** Nutritional support is a key component of pediatric intensive care. Inadequate nutritional intake has been associated with prolonged mechanical ventilation, increased nosocomial infections, longer intensive care and hospital stays, and higher mortality.

Current international guidelines recommend early nutritional assessment and suggest indirect calorimetry as the preferred method for determining resting energy expenditure (REE). However, nutritional prescriptions in routine clinical practice frequently rely on predictive equations, particularly the Schofield equation, which may not accurately reflect the metabolic requirements of critically ill children.

A previous retrospective study conducted in our PICU, involving 141 mechanically ventilated children, demonstrated persistent variability in energy intake on days 2 and 3 despite the implementation of a standardized enteral nutrition protocol. These findings suggest that individualizing energy targets using directly measured REE could improve nutritional adequacy.

**Study Design and Population** CALI-PED is a single-center, prospective, non-randomized, interventional pilot study conducted at Montpellier University Hospital, France.

The prospective cohort will include 50 children younger than 18 years, weighing at least 10 kg, receiving invasive mechanical ventilation through a cuffed endotracheal tube, with an expected ventilation duration exceeding 48 hours.

The prospective cohort will be compared with a previously collected historical cohort of 141 mechanically ventilated children managed using conventional nutritional targets based on the Schofield predictive equation.

**Intervention** In the prospective cohort, REE will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit.

Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Before each measurement, respiratory settings must have remained unchanged for at least one hour. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period.

Daily enteral energy prescriptions will be adjusted according to the measured REE, expressed in kcal/day and kcal/kg/day.

**Primary Outcome** The primary outcome is the interindividual dispersion of the ratio between actual energy intake and the reference energy target on days 2 and 3 of mechanical ventilation.

The reference energy target will be defined as:

  • Measured REE obtained by indirect calorimetry in the prospective cohort.
  • Estimated energy requirements calculated using the Schofield equation in the historical cohort.

Interindividual dispersion will be assessed using the interquartile range and coefficient of variation.

**Secondary Outcomes**

Secondary outcomes include:

  • Comparison of protein intake (g/kg/day) between cohorts on days 2 and 3.
  • Comparison of Schofield-predicted energy requirements with indirect calorimetry-measured REE in the prospective cohort.
  • Description of daily changes in measured REE during invasive mechanical ventilation, up to day 7.
  • Exploratory comparison of mechanical ventilation duration, PICU length of stay, and incidence of nosocomial infections between cohorts.

Nosocomial infections will be defined as infections occurring at least 48 hours after admission, according to Centers for Disease Control and Prevention criteria.

**Statistical Analysis** The distributions of energy intake adequacy ratios will be compared between the prospective and historical cohorts using appropriate statistical methods. Normality will be assessed using the Shapiro-Wilk test, and continuous variables will be compared using parametric or non-parametric tests as appropriate.

Additional analyses may account for differences between the prospective and historical cohorts, including propensity score methods.

Clinical outcomes will be considered exploratory, as the study is not powered to demonstrate differences in clinical endpoints.

**Study Duration and Ethical Considerations** The recruitment period is expected to last 30 months. Participants will be followed until PICU discharge or day 28 after inclusion, whichever occurs first.

The study was approved by the Comité de Protection des Personnes Île-de-France VII on August 5, 2026 (reference 26.02032.000560). Written informed consent will be obtained from at least one parent or legal guardian, and assent will be obtained from the child whenever feasible.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

50

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

    • Occitanie
      • Montpellier, Occitanie, Ranska, 34295
        • Montpellier University Hospital - Arnaud de Villeneuve Hospital
        • Ottaa yhteyttä:
        • Päätutkija:
          • Arthur Gavotto, MD, PhD

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

1 sekunti - 17 vuotta (Lapsi)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Children younger than 18 years of age.
  • Body weight ≥10 kg.
  • Invasive mechanical ventilation.
  • Expected duration of invasive mechanical ventilation >48 hours.
  • Child's assent to participate, whenever feasible.
  • Written informed consent obtained from at least one parent or legal guardian.

Exclusion Criteria:

  • Limitation or withdrawal of life-sustaining treatment planned at the time of admission to the pediatric intensive care unit.
  • Brain death.
  • Requirement for a specific dietary regimen due to an underlying condition, including diabetic ketoacidosis or an inherited metabolic disorder.
  • Gastrointestinal disorders interfering with enteral nutrition, including short bowel syndrome or malabsorption.
  • Participation in another research study with an ongoing exclusion period.
  • Concurrent participation in another interventional clinical trial that could interfere with the present study.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Ei käytössä
  • Inventiomalli: Yksittäinen ryhmätehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Indirect Calorimetry-Guided Nutrition

Fifty mechanically ventilated children will receive individualized enteral nutritional support guided by daily indirect calorimetry measurements. Resting energy expenditure will be measured from day 2 until extubation, for a maximum of seven days, and enteral caloric prescriptions will be adjusted accordingly.

Resting energy expenditure (REE) will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit. Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period. Daily enteral caloric prescriptions will be adjusted according to the measured REE.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Interindividual Variability in Energy Intake Adequacy on Days 2 and 3 of Mechanical Ventilation
Aikaikkuna: Days 2 and 3 of invasive mechanical ventilation

Interindividual variability in the ratio of actual energy intake (kcal/kg/day) to the reference energy target will be compared between the prospective and historical cohorts on days 2 and 3 of mechanical ventilation.

The reference energy target is defined as resting energy expenditure measured by indirect calorimetry in the prospective cohort and energy requirements estimated using the Schofield equation in the historical cohort.

Interindividual variability will be primarily quantified using the interquartile range (IQR) of the energy intake adequacy ratio. The coefficient of variation (CV) will be calculated as a complementary measure of dispersion.

Days 2 and 3 of invasive mechanical ventilation

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Daily Protein Intake on Days 2 of Mechanical Ventilation
Aikaikkuna: Days 2 of invasive mechanical ventilation

Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 2 of invasive mechanical ventilation.

Days 2 of invasive mechanical ventilation
Daily Protein Intake on Days 3 of Mechanical Ventilation
Aikaikkuna: Days 3 of invasive mechanical ventilation

Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 3 of invasive mechanical ventilation.

Days 3 of invasive mechanical ventilation
Difference Between Predicted and Measured Resting Energy Expenditure
Aikaikkuna: Days 2 to 7 of invasive mechanical ventilation

Difference between energy requirements estimated using the Schofield predictive equation and resting energy expenditure measured by indirect calorimetry in the prospective cohort, expressed in kcal/day.

Days 2 to 7 of invasive mechanical ventilation
Daily Changes in Measured Resting Energy Expenditure
Aikaikkuna: Days 2 to 7 of invasive mechanical ventilation

Daily resting energy expenditure measured by indirect calorimetry, expressed in kcal/day, will be described from day 2 until extubation, for a maximum of seven days of invasive mechanical ventilation, in the prospective cohort.

Days 2 to 7 of invasive mechanical ventilation
Duration of Invasive Mechanical Ventilation
Aikaikkuna: From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment

Duration of invasive mechanical ventilation, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
Pediatric Intensive Care Unit Length of Stay
Aikaikkuna: From PICU admission until PICU discharge, assessed up to day 28 after enrollment

Length of stay in the pediatric intensive care unit, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

From PICU admission until PICU discharge, assessed up to day 28 after enrollment
Incidence of Nosocomial Infections
Aikaikkuna: From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first

Proportion of patients developing at least one nosocomial infection, defined as an infection occurring at least 48 hours after PICU admission according to Centers for Disease Control and Prevention criteria. This exploratory clinical outcome will be compared between the prospective and historical cohorts.

From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Arthur Gavotto, University Hospital, Montpellier

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Perjantai 1. tammikuuta 2027

Ensisijainen valmistuminen (Arvioitu)

Perjantai 1. kesäkuuta 2029

Opintojen valmistuminen (Arvioitu)

Sunnuntai 1. heinäkuuta 2029

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 10. marraskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Tiistai 10. marraskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Tiistai 17. marraskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 17. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 10. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

Individual participant data will not be made publicly available due to the sensitive nature of clinical information collected from critically ill pediatric patients and applicable data protection requirements. Study results will be disseminated through scientific publications and presentations in aggregated form.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa